Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Central line-associated bloodstream infections

This article was originally published in The Gray Sheet

Executive Summary

Incidents are down an estimated 18% from predicted levels nationally, according to a May 27 report from the Centers for Disease Control and Prevention. CDC's "First State-Specific Healthcare-Associated Infections Summary Data Report" looked at central line-associated bloodstream infections (CLABSI) because states most frequently mandate reporting as part of the National Healthcare Safety Network, the CDC-sponsored framework through which hospitals are pursuing efforts to reduce infection rates. The 1report notes 4,615 CLABSIs were reported from January 2009 through June 2009 at 1,538 facilities nationally
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT028929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel